Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prevention studies with pentoxifylline: new clinical projects

I Eugène-Jolchine1, N Milpied

  • 1Recherche Clinique, Laboratoires Hoechst, Puteaux, France.

Journal of Cardiovascular Pharmacology
|January 1, 1995
PubMed
Summary

Pentoxifylline (PTX) may help treat various diseases by modifying cytokine dysregulation. Clinical trials are investigating its potential benefits in bone marrow transplantation, respiratory insufficiency, and peripheral arterial disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Peripheral T cell lymphomas: diagnosis and treatment].

La Revue de medecine interne·2020
Same author

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia.

Journal of internal medicine·2017
Same author

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party.

Bone marrow transplantation·2017
Same author

« Malignant » Rosacea as a sign of systemic marginal zone lymphoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017
Same author

Severe acute GvHD following administration of ipilimumab for early relapse of AML after haploidentical stem cell transplantation.

Bone marrow transplantation·2017
Same author

The choice of in-hospital or home administration for plerixafor injection to poor mobilizers has no adverse consequence on subsequent hematopoietic stem cell harvest.

Bone marrow transplantation·2017

Area of Science:

  • Pharmacology
  • Immunology
  • Clinical Medicine

Background:

  • Pentoxifylline (PTX), a methylxanthine derivative, modulates cytokine dysregulation.
  • While effective for intermittent claudication, PTX's broader clinical utility requires further investigation.
  • Animal models suggest PTX efficacy in various conditions, but human data is limited.

Purpose of the Study:

  • To evaluate the efficacy of Pentoxifylline (PTX) in three distinct clinical conditions.
  • To assess PTX's potential to reduce transplant-related toxicity in allogeneic bone marrow transplantation.
  • To determine if PTX can decrease infectious exacerbations in severe chronic respiratory insufficiency.
  • To explore PTX's long-term preventive effects in peripheral arterial disease.

Main Methods:

Related Experiment Videos

  • A placebo-controlled trial is assessing PTX for reducing bone marrow transplant toxicity.
  • An ongoing study compares infectious exacerbations in patients with severe chronic respiratory insufficiency receiving PTX or placebo.
  • A long-term prevention study is planned for patients with peripheral arterial disease.

Main Results:

  • Results from these ongoing trials are pending.
  • The study designs aim to provide robust data on PTX efficacy and safety.
  • This research will clarify PTX's role in managing complex diseases.

Conclusions:

  • Pentoxifylline (PTX) shows promise for treating conditions beyond intermittent claudication.
  • Further clinical research is essential to establish PTX's therapeutic value in transplantation, respiratory insufficiency, and peripheral arterial disease.